Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.5M
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
7.91M
-
Shares change
-
+509K
-
Total reported value, excl. options
-
$91.8M
-
Value change
-
+$5.9M
-
Number of buys
-
32
-
Number of sells
-
-14
-
Price
-
$11.61
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2014
58 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2014.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.91M shares
of 50.5M outstanding shares and own 15.66% of the company stock.
Largest 10 shareholders include Broadfin Capital, LLC (2.13M shares), DEERFIELD MANAGEMENT CO (1.28M shares), BlackRock Fund Advisors (776K shares), JPMORGAN CHASE & CO (696K shares), Sectoral Asset Management Inc (660K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (470K shares), KENNEDY CAPITAL MANAGEMENT, INC. (200K shares), VANGUARD GROUP INC (156K shares), FEDERATED INVESTORS INC /PA/ (151K shares), and CHARLEMAGNE CAPITAL LTD (122K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.